For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Avanir Pharmaceuticals

Calculating rank

USPTO Granted Patents = 38

% Expired Patents = 71.1

CIPO Patents = 2

EPO Patents = 4

Trademarks = 5

Forward Citations = 598

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Jagadish C Sircar (28 out of 36 patents)

Wenbin Ying (19 out of 54 patents)

Sunil Kumar K C (14 out of 23 patents)

4. Robert Z Florkiewicz (13 out of 25 patents)

5. Federico C A Gaeta (13 out of 24 patents)

6. Jerry Anchin (13 out of 14 patents)

7. Andrew J Baird (13 out of 36 patents)

8. Mark L Richards (9 out of 11 patents)

9. Laura E Pope (6 out of 8 patents)

10. Michael W Major (5 out of 7 patents)

11. Michael G Campbell (5 out of 15 patents)

12. Sunil Kumar Kc (4 out of 125 patents)

13. Matt Johnson (4 out of 4 patents)

14. Cunxiang Zhao (4 out of 4 patents)

15. Weihua Meng (4 out of 4 patents)

Core Competencies:

Dextromethorphan

Macrophage Migration Inhibitory Factor

Pharmaceutical Compositions

Benzimidazole Compounds

IgE Modulators

Deuterated Compounds

Thienopyridinone Derivatives

Naphthyridine Derivatives

Viral Replication Inhibition

Cellular Proliferation

Neurological Disorders

Hyperproliferative Skin Disorders

38 patents: Sort by Forward Citations

1. 12291505 - Methods for the synthesis of deuterated dextromethorphan (2025-05-06),

2. 11845731 - Methods for the synthesis of deuterated dextromethorphan (2023-12-19),

3. 10865187 - Methods for the synthesis of deuterated dextromethorphan (2020-12-15),

4. 10730841 - Methods for the synthesis of deuterated dextromethorphan (2020-08-04),

5. 8227484 - Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders (2012-07-24),

6. 7732146 - Method for screening an agent that modulates activity of macrophage migration inhibitory factor (2010-06-08),

7. 7659282 - Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders (2010-02-09),

8. 7514225 - Method for screening an agent that modulates activity of macrophage migration inhibitory factor (2009-04-07),

9. 7432374 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2008-10-07),

10. 7375118 - Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation (2008-05-20),

11. 7365200 - Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors (2008-04-29),

12. 7361760 - Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases (2008-04-22),

13. 7312221 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2007-12-25),

14. 7312220 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2007-12-25),

15. 7282518 - Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation (2007-10-16),

Company Overview

Avanir Pharmaceuticals is a biopharmaceutical company based in San Diego, California, focused on developing innovative therapies for central nervous system disorders. The company specializes in addressing unmet medical needs in conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Avanir is committed to advancing research and providing effective treatment options that enhance the quality of life for patients and their families.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

38 Patents

#164 in San Diego, CA

#2,137 in California

#9,043 in US

#17,876 in the World

San Diego, CA, United States of America

Avanir Pharmaceuticals

Forward Citations = 598

29 inventors:

Jagadish C Sircar (28 out of 36 patents)

Wenbin Ying (19 out of 54 patents)

Sunil Kumar K C (14 out of 23 patents)

4. Robert Z Florkiewicz (13 out of 25 patents)

5. Federico C A Gaeta (13 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Avanir Pharmaceuticals. Retrieved from https://idiyas.com/company/avanir-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…